Federal health researchers identified 13 cases of congenital measles and 112 infections among pregnant women between January 2025 and September 2026, raising concerns about serious complications for mothers and newborns.

By yourNEWS Media Newsroom

Thirteen babies were born with measles in the United States between January 2025 and September 2026, marking the return of a condition rarely encountered by American physicians for decades as the country experiences its largest measles outbreaks in more than 30 years.

The findings, published Monday, Nov. 16, in the medical journal NEJM Evidence, also documented 112 confirmed measles infections among pregnant women across 16 U.S. jurisdictions. Researchers identified cases involving maternal pneumonia, premature births, pregnancy losses and serious complications affecting newborns.

According to the preliminary analysis conducted primarily by Centers for Disease Control and Prevention researchers, 96% of the infections among pregnant women occurred during large outbreaks involving at least 50 cases.

Congenital measles develops when the virus passes from an infected pregnant woman to her unborn child. The infection can cause fever, rash, pneumonia and potentially life-threatening neurological complications shortly after birth.

Michael Osterholm, director of the University of Minnesota’s Center for Infectious Disease Research and Policy, described the reappearance of the condition as a significant development.

“This is a brand new phenomenon,” Osterholm told The Associated Press, referring to its emergence in the current U.S. health care environment.

The newly published research examined cases reported to the CDC between Jan. 1, 2025, and Sept. 28, 2026. Of the 112 pregnant women diagnosed with measles, 26 required hospitalization for reasons unrelated to labor, including 11 who developed pneumonia.

Two women experienced respiratory failure, and one required intensive care.

Researchers documented 21 pregnancy outcomes occurring within 14 days of the mother’s initial measles rash. Those cases included 19 live births, one miscarriage and one stillbirth.

Among the 19 newborns, eight were born prematurely and eight required admission to neonatal intensive care units.

Sixteen infants underwent laboratory testing for measles, with 13 testing positive within their first 10 days of life. All 13 met the researchers’ definition of congenital measles.

Six infected newborns developed symptoms, including one infant whose condition was consistent with meningoencephalitis, a serious inflammation affecting the brain and surrounding protective membranes.

The findings also revealed substantial gaps in maternal vaccination histories.

Of the 112 pregnant women infected, 110, or approximately 98%, were either unvaccinated against measles before pregnancy or had an unknown vaccination status. One woman had documentation of receiving a single measles, mumps and rubella vaccine dose, while another had received two doses.

The researchers emphasized that the combined category includes women whose vaccination histories could not be established and does not mean all 110 were confirmed to be unvaccinated.

The study’s authors also cautioned that their conclusions were preliminary because pregnancy outcomes were unavailable for many patients.

Of the 112 pregnant women, researchers had documented pregnancy outcomes for 37, while 19 pregnancies were presumed ongoing and outcomes remained unknown for 56.

That missing information limits researchers’ ability to determine the full extent of complications associated with the reported infections.

The University of Minnesota’s infectious disease research center said the findings demonstrated how measles outbreaks are affecting populations that had rarely encountered the disease in recent decades.

The condition has become particularly concerning because measles infections during pregnancy can affect both the mother’s health and the development and survival of the infant.

Dr. Adam Ratner, a member of the American Academy of Pediatrics’ infectious diseases committee, said the increase in congenital infections reflects the broader resurgence of measles.

“We’re now seeing levels of measles that we haven’t seen in 30 years,” Ratner said.

Measles is among the most contagious human viruses and spreads through airborne particles released when an infected person breathes, coughs or sneezes. The virus can remain infectious in the air for up to two hours after an infected person leaves an enclosed space.

Most cases involve fever, cough, runny nose, red eyes and a distinctive rash. However, complications can include pneumonia, brain inflammation and death, particularly among infants and people with weakened immune systems.

Doctors are also concerned about subacute sclerosing panencephalitis, or SSPE, a rare but almost always fatal neurological disorder that can develop years after a measles infection.

Ratner said evidence suggests that children infected with measles before birth may face an elevated risk of developing the disorder and could experience its onset earlier than other infected children.

Because congenital measles has historically been uncommon in the United States, researchers have limited information about the long-term outcomes for affected infants.

The American Academy of Pediatrics has issued updated clinical guidance to help physicians recognize and manage infections in newborns exposed during pregnancy.

The organization estimates that approximately 25% to 30% of babies born to women who contract measles shortly before delivery may become infected.

Physicians generally administer the first routine dose of the measles, mumps and rubella vaccine between 12 and 15 months of age, leaving newborns dependent on antibodies passed from their mothers and protection provided by broader community immunity.

The MMR vaccine is not recommended during pregnancy because it contains live attenuated viruses. Health authorities recommend that women establish immunity before becoming pregnant.

For pregnant women without evidence of immunity who are exposed to measles, the CDC recommends intravenous immunoglobulin within six days of exposure to reduce the risk of infection or serious complications.

The newly published study also recommends administering immunoglobulin at birth to infants exposed to measles in the womb.

The findings come amid a sustained increase in measles infections nationwide.

According to CDC surveillance figures updated Nov. 13, the United States had recorded 5,412 confirmed measles cases in 2026 as of Nov. 12, compared with 2,289 cases throughout 2025.

The two-year total exceeds 7,700 confirmed infections, reflecting a substantial increase from the relatively low case counts recorded during much of the previous two decades.

National childhood vaccination coverage has also declined.

CDC figures show that 92.4% of American kindergarten students received the required MMR vaccinations during the 2025-26 school year, below the approximately 95% coverage generally considered necessary to prevent sustained measles transmission in communities.

Vaccination rates vary significantly by state and county, leaving some communities more vulnerable to outbreaks than national averages suggest.

The resurgence has raised concerns about whether the United States can maintain the measles elimination status it achieved in 2000, when sustained domestic transmission was declared interrupted.

The Pan American Health Organization is reviewing surveillance evidence to determine whether the country continues to meet the criteria for elimination.

The return of congenital measles adds another complication to that assessment, demonstrating that outbreaks are reaching pregnant women and newborns who face heightened risks from infection.

Researchers emphasized that continued monitoring is necessary to determine the full effects of measles exposure during pregnancy, including potential neurological complications that may not become apparent until years after birth.

The preliminary findings also underscore the importance of collecting linked medical records for mothers and infants to better understand pregnancy outcomes and identify newborns requiring additional monitoring.

With measles cases continuing across multiple states, physicians and public health officials are preparing for the possibility of additional congenital infections.

The study’s authors concluded that improving vaccination coverage before pregnancy and maintaining high community immunity remain important measures for preventing maternal infections, premature deliveries and serious illness among newborns.

Original article